GLP-1s Tied to Lower Risk of Substance Use Disorders
A study of 142,000 patients suggests GLP-1 medications may influence brain pathways involved in cravings for nicotine, opioids, and alcohol.
Tag: sedation and pain management
All
Latest
GLP-1s Tied to Lower Risk of Substance Use Disorders
A study of 142,000 patients suggests GLP-1 medications may influence brain pathways involved in cravings for nicotine, opioids, and alcohol.
Read More
Draeger Expands Corrections for Atlan A350 and A350 XL Anesthesia Workstations
A manufacturing error in the ventilator motor assembly may cause mechanical ventilation to fail before or during use, according to an FDA early alert.
Read More
Research Aims to Improve ICU Sleep, Reduce Delirium
Researchers at UC San Diego Health are leading a $12 million multi-site study to identify effective sleep-promotion strategies for critically ill patients.
Read More
Older Adults Turning to Cannabis Edibles
New research finds that people over age 60 use cannabis primarily to manage pain and sleep, often relying on word of mouth over medical advice.
Read More
Clinician Bias Linked to Opioid Stigma in Sickle Cell Care
Negative descriptors in clinician notes for sickle cell patients are closely associated with stigma surrounding opioid use.
Read More
Neonatal Respiratory Depression Tied to Maternal Oxycodone Use During Breastfeeding
A case report suggests high doses of oxycodone in breastfeeding mothers can lead to apnea and bradycardia in newborns due to immature metabolic pathways.
Read More
NNAAL Linked to Adverse Maternal/Fetal Outcomes
A non-narcotic analgesics allergy label (NNAAL) is associated with several adverse perinatal outcomes, including greater rates of NICU admission, preterm birth, and more.
Read More
Your Body Has a Microscopic Thermometer
First-ever molecular snapshots show the body’s “cold sensor” in action, with implications for treating pain, migraines, and dry eye.
Read More
Emergency Intubation Study to Examine Neuromuscular Blockers
The INSPIRE study will examine whether seriously ill patients being intubated should receive sedation alone or with the addition of a neuromuscular blocker.
Read More
Gene Therapy ‘Switch’ May Offer Nonaddictive Pain Relief
A new gene therapy may offer pain relief without addiction, targeting only pain signals and leaving the rest of the brain untouched.
Read More
17% of Patients Perceived as Difficult by Physicians
Physicians perceive one-in-six patient visits in non-psychiatric clinics as “difficult,” and these encounters are more likely to involve patients with mental health disorders or chronic pain.
Read More
WHO: Opioid Agonist Treatment an Essential Health Service
The World Health Organization says opioid agonist maintenance treatment (OAMT) is a cost-effective intervention that reduces mortality and morbidity.
Read More
Give Them Comfort: Controlling COPD Symptoms at the End of Life (Part I)
Patients’ last days of COPD can be characterized by depression, anxiety, pain, and dyspnea. Clinicians must be alert to patient discomfort and offer appropriate palliative care and reassurance.
Read More
Older Women Less Likely to Receive ER Morphine for Chest Pain
Women over age 57 are less likely to receive IV morphine in the emergency room when presenting with chest pain, compared to younger women, younger men, and older men.
Read More
Federal Government to Reclassify Marijuana
President Trump signed an executive order on Thursday to reclassify marijuana from a Schedule I to a Schedule III drug.
Read More
Ketamine or Etomidate When Intubating Patients?
Results of a clinical trial comparing sedation of intubated patients using ketamine or etomidate found greater risks and fewer benefits when using ketamine.
Read More
Cesarean Delivery Linked to Higher Risk of Pain, Sleep Problems
Women who had C-sections are 16% more likely to develop new sleep disorders—such as insomnia or sleep apnea—within a year after childbirth.
Read More
New FDA Guidance on Non-Opioid Options for Chronic Pain
The FDA issued draft guidance to accelerate safe and effective non-opioid treatments and to reduce prescription-related opioid misuse.
Read More
Most Chronic Pain Patients Stop Use of Medical Cannabis Within One Year
A small study found 57.9% of patients using medical cannabis discontinued treatment within 12 months, and 44.7% quit in the first three months.
Read More
Lidocaine Local Anesthetic Poisonings/Deaths Nearly Tripled
Poisonings and deaths linked to the use of the local anesthetic lidocaine have nearly tripled in the US over the past decade, despite drops for in poisonings and deaths related to other anesthetics.
Read More
Masimo EEG Brain Function Monitoring Reduced Pediatric Anesthesia Administration
EEG-guided anesthesia using Masimo technology significantly reduced pediatric anesthesia emergence delirium, time to emergence and discharge, and cost of care by minimizing sevoflurane exposure.
Read More
Should Physiotherapists Be First Point of Contact for Patients?
Patients who saw physiotherapists first experienced a two-month reduction in wait times and earlier access to educational pain management programs.
Read More
Evidence Supports Buprenorphine for Acute Pain in Patients with Opioid Use Disorder
Continuing buprenorphine during acute pain episodes for people with opioid use disorder (OUD) may lead to lower or similar pain severity compared to discontinuation.
Read More
Best Practices for Cannabis/Cannabinoids Use in Chronic Pain Patients
As the use of cannabis for chronic pain increases, the American College of Physicians has published best practices for physicians when counseling patients.
Read More